tirzepatide glen carbon GLP-1/GIP Rx Compounded Tirzepatide (GLP-1/GIP)

Cholecystitis was reported by 0.6% of WEGOVY injection-treated adult patients and 0.2% of placebo- treated patients

Prescriber 34 (7), 2728

For people who rely on Medicaid, including Martinez, the last option is not possible

At Health Express Clinics , we prescribe either based on: Primary diagnosis (type 2 diabetes vs obesity) Insurance eligibility Response to prior treatments like semaglutide What the Research Says Tirzepatide Results Here are key findings from recent studies: SURMOUNT-1 Trial (NEJM, 2022): Adults lost 22.5% of body weight over 72 weeks More effective than semaglutide at equivalent durations JAMA (2023): Tirzepatide showed significant improvements in A1c, triglycerides, and waist circumference Participants reported higher satisfaction and adherence compared to other weight loss medications Lancet Diabetes & Endocrinology (2023): Tirzepatide consistently outperformed other medications in head-to-head comparisons These are not just cosmetic results